This grant allows organizations with specific NIH grants to apply for a change of recipient status, called Successor-in-Interest; approval is not guaranteed.
NIH offers funding for expanding existing projects or programs under specific criteria through Competing Revisions to NIH single project research grants and cooperative agreements without requiring clinical trials.
Funding available for NIH grant applications responding to presidentially declared disasters or public health emergencies through Emergency Notices of Special Interest.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.